AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Conjugated Oestrogens in South Africa
6 products registered with SAHPRA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| PREMELLE 5 | 32/21.8/0577 | Pfizer Laboratories (Pty) Ltd | suspended | 11 Jul 2025 |
| PREMELLE LD-0,3/1,5 | 36/21.8/0197 | Pfizer Laboratories (Pty) Ltd | suspended | 11 Jul 2025 |
| PREMELLE 2,5 | 32/21.8/0576 | Pfizer Laboratories (Pty) Ltd | suspended | 5 Jun 2025 |
| PREMARIN 1,25 | G/21.8.1/3014 | Pfizer Laboratories (Pty) Ltd | active | 1 Jan 1900 |
| PREMARIN 0,625 | G/21.8.1/3015 | Pfizer Laboratories (Pty) Ltd | active | 1 Jan 1900 |
| PREMARIN 0,3 | G/21.8.1/3016 | Pfizer Laboratories (Pty) Ltd | active | 1 Jan 1900 |
Conjugated Oestrogens — SAHPRA Registration Details
SAHPRA (South Africa) has 6 registered products containing Conjugated Oestrogens, of which 3 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Conjugated Oestrogens registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.